StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.56+0.08 (+5.41%)

Close on Nov 17, 2026Market cap $878.81KP/E –Yield –

Universe Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Universe Pharmaceuticals's pe ratio was 3.0× on Nov 30, 2022, against 4.6× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Nov 30, 20223.0×+0.3
2021Dec 31, 20212.7×–

More Universe Pharmaceuticals figures

See a number that looks wrong?